Pharma Stocks up 4% after Tariff Exemption

Nifty Pharma went up by 4% on April 3 after US President Donald Trump announced exemptions on the pharma sector in his tariff policy. Shares of Sun Pharma, Gland Pharma and IPCA Labs went up by 4% each.

“India and the U.S. share a strong and growing bilateral trade relationship, with a shared vision to double trade to $500 billion under the Mission 500 initiative. Pharmaceuticals remain a cornerstone of this partnership, as India plays a vital role in global and U.S. healthcare by ensuring a steady supply of affordable medicines,” said Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA).

“Pharmaceuticals have been exempted from tariffs. The decision underscores the critical role of cost-effective, life-saving generic medicines in public health, economic stability, and national security,” he added.

Notably, the US accounts for 30% of the pharmaceutical industry’s total shipments.